News Releases
Aug 18, 2010 (BUSINESS WIRE) -- Magellan Health Services
|
WHAT |
ICORE Healthcare, a Magellan Health Services company, is bringing together international thought leaders to share the latest insights, key issues and emerging trends in oncology management at its 7th annual Oncology Summit. |
|
|
WHO |
The Oncology Summit is open to health plan executives, oncology practice managers, distributors, specialty pharmacies and pharmaceutical manufacturers. Participants can register online at http://www.regonline.com/register/checkin.aspx?EventId=867536 until September 8, 2010. |
|
| Guest speakers and ICORE subject matter experts include: | ||
|
â- Peter Clark, MD - National Institute for Clinical Excellence (London, UK) |
||
|
â- Jeff Forringer - IntrinsiQ (Waltham) |
||
|
â- Alan Lotvin, MD - ICORE (Orlando) |
||
|
â- Kjel Johnson, PharmD, BCPS, FCCP, FAMCP - ICORE (Orlando) |
||
| Speakers will address health care legislation and its impact on cancer care, personalized cancer treatment trends, comparative effectiveness and myths versus realities. The event kicks off with a special panel that includes members from provider, payor, pharmacy and patient advocate communities. | ||
|
WHERE |
New York Marriott Marquis |
|
| 1535 Broadway, New York 10036 | ||
|
WHEN |
7th Annual Oncology Summit |
|
| Friday, September 10, 2010 - 8 a.m. to 5 p.m. | ||
|
WHY |
With new oncology drugs in the marketplace, broader indications for them, and increasing demand continuing to drive up costs associated with these specialty pharmaceuticals, health plans, providers, pharmaceutical companies and specialty pharmacy managers must collaborate to find solutions that control costs, while ensuring patients receive the highest quality of care. |
|
| The Oncology Summit provides an open venue to tackle the hard-hitting issues of the industry, such as: | ||
|
â- Understand how health care reform legislation will impact oncology care |
||
| â- Learn about the comparative effectiveness experience in the United Kingdom | ||
| â- Understand the impact of oncology trends over the next five years | ||
| â- Assess the opportunities and challenges associated with treatment variability, off-label drug utilization and genetic testing | ||
About Magellan/ICORE
ICORE Healthcare, LLC, is redefining how America's health plans manage complex specialty pharmaceuticals to ensure clinical excellence, while minimizing the costs in one of the fastest-growing areas of health care spending. ICORE is part of Magellan Health Services, Inc. (NASDAQ:MGLN), a leading specialty health care management organization whose customers include health plans, employers and government agencies nationwide.
SOURCE: Magellan Health Services
Mary Little 602-417-0682 mlittle@c-k.com
Copyright Business Wire 2010